Buckley's

Buckley's is a Canadian over-the-counter medicine brand operated by W. K. Buckley Limited, a company headquartered in Mississauga, Ontario. The business was founded in Toronto in 1919 by William Knapp Buckley, and its best-known product is Buckley's Original Mixture, a cough syrup that became closely associated with an unusually strong and unpleasant taste. Rather than treating that characteristic as a weakness, the company made it central to its identity and advertising. The resulting positioning is captured by the long-running line, "It tastes awful. And it works." The original product was developed as a cough and congestion remedy and has been sold in various formulations over the brand's long history. Descriptions of the mixture identify ingredients including ammonium carbonate, potassium bicarbonate, camphor, menthol, Canada balsam, sodium cyclamate, pine needle oil, and a tincture of capsicum. Product formulations and regulatory status can change over time, so ingredient lists and permitted claims should be checked against current Canadian packaging and regulatory information. After William Knapp Buckley died in 1978, his adopted son Frank Buckley became president of the company. In the mid-1980s, Frank also became a public spokesperson, a move that helped turn the family name and the product's taste into a distinctive consumer-marketing platform. The brand's advertising generally uses self-deprecating humor: the medicine is presented as difficult to take, while the unpleasantness is framed as evidence of seriousness and effectiveness rather than concealed. Buckley's later broadened its portfolio beyond its original cough syrup. Its range has included products for cough, cold, congestion, and related symptoms, as well as children's medicines sold under the Jack & Jill name. The company also marketed formulations containing dextromethorphan, including Buckley's DM and Buckley's Dry Cough. Buckley's DM was withdrawn from sale in Canada in 2016, while other products containing the ingredient continued to be sold according to the supplied reference material. Novartis acquired W. K. Buckley Limited in 2002, making Buckley's part of the multinational pharmaceutical group's consumer-health activities. The brand remains primarily associated with the Canadian market and with nonprescription respiratory remedies. Its distinctive value lies less in broad global reach than in strong domestic recognition, a memorable product experience, and an advertising proposition that openly acknowledges the syrup's taste. In March 2017, Health Canada recalled certain Buckley's products because of a choking hazard associated with a faulty plastic seal, illustrating the regulatory and packaging responsibilities that accompany the brand's continued sale.

W. K. Buckley Limited began in Toronto in 1919, when William Knapp Buckley founded the company and developed Buckley's Original Mixture, a cough syrup intended to relieve cough and congestion. The product became the foundation of a Canadian medicine business and ultimately gave its name to the broader Buckley's brand. Its identity was shaped not only by its therapeutic category but also by the strong sensory reaction associated with the syrup. The product was widely characterized as having an exceptionally unpleasant taste, a feature that the company eventually transformed into a marketing asset. William Knapp Buckley remained associated with the business until his death in 1978. Following his death, his adopted son Frank Buckley became president. During the mid-1980s, Frank Buckley also served as the brand's spokesperson. This period marked an important communications shift: instead of attempting to hide the medicine's taste, advertising acknowledged it directly and connected it with the message, "It tastes awful. And it works." The slogan and related self-deprecating advertising gave Buckley's a distinctive position in Canada's crowded cough-and-cold category. The brand's humor made an otherwise negative product attribute memorable and helped establish a recognizable connection between the Buckley family, the syrup, and Canadian consumer culture. Over time, the company expanded beyond the original mixture into additional cough, cold, congestion, and children's products. Children's medicines were marketed under the Jack & Jill name, while the Buckley's portfolio included products such as Buckley's DM and Buckley's Dry Cough. The products' active ingredients and formulations have not been uniform across the range. Buckley's DM, which contained dextromethorphan, was discontinued in Canada in 2016, although other dextromethorphan-containing mixtures remained available according to the supplied reference material. A major ownership transition occurred in 2002, when Novartis acquired W. K. Buckley Limited. The acquisition placed the Canadian company within the structure of a global pharmaceutical group while preserving the Buckley's brand identity and its principal association with over-the-counter respiratory medicines. The business is located in Mississauga, Ontario, and its principal market remains Canada. The brand has also operated within the safety and compliance framework applicable to nonprescription medicines. In March 2017, Health Canada recalled affected Buckley's products because a faulty plastic seal presented a choking hazard. The recall demonstrates that the brand's history is not limited to product development and advertising; packaging design, product stewardship, and regulatory intervention have also affected its operations. Buckley's remains a specialized Canadian consumer-health brand. Its enduring competitive distinction is the combination of a long-established cough remedy, a recognizable family and company name, and unusually direct advertising about taste. The brand's story illustrates how a product defect from a conventional marketing perspective can be reframed as a memorable promise, while also showing how ownership changes, formulation decisions, and product-safety requirements shape a long-running medicine business.

1. 2017Health Canada product recall

   Health Canada recalled affected Buckley's products because a faulty plastic seal posed a choking hazard.

   Source
2. 2016Buckley's DM withdrawn in Canada

   The company stopped selling Buckley's DM in Canada, while other formulations containing dextromethorphan remained available.

   Source
3. 2002Novartis acquisition

   Novartis purchased W. K. Buckley Limited, making the Canadian brand part of its multinational consumer-health portfolio.

   Source
4. 1980Frank Buckley becomes brand spokesperson

   In the mid-1980s, Frank Buckley became a public spokesperson and the brand developed its famous taste-based advertising line.

   Source
5. 1978Frank Buckley succeeds William Knapp Buckley

   Following William Knapp Buckley's death, his adopted son Frank Buckley became president of the company.

   Source
6. 1919Company founded and Original Mixture introduced

   William Knapp Buckley founded the company in Toronto and developed the cough syrup that became Buckley's Original Mixture.

   Source

A Canadian over-the-counter respiratory-health brand differentiated by a candid, humorous promise that its unpleasant taste is part of its effectiveness.

• Buckley's Original MixtureCough and congestion syrup1919

  The brand's foundational cough syrup, developed in 1919 and associated with relief of cough and congestion. Its strongly unpleasant taste became the central subject of Buckley's advertising rather than a characteristic the company tried to disguise. Reported ingredients include ammonium carbonate, potassium bicarbonate, camphor, menthol, Canada balsam, sodium cyclamate, pine needle oil, and capsicum tincture; current formulations should be verified from official packaging.

• Buckley's DMCough medicine

  A Buckley's cough product containing dextromethorphan. The company discontinued its sale in Canada in 2016. It is included as a historical product rather than a current offering.

• Buckley's Dry CoughDry-cough medicine

  A Buckley's formulation for dry coughs. The supplied reference material identifies it as another product containing dextromethorphan that continued to be sold after Buckley's DM was discontinued in Canada. Availability and formulation may vary by period and market.

• Jack & JillChildren's medicines

  A children's medicine line offered by the company under the Jack & Jill brand name. It extends the business beyond adult cough syrup into pediatric cold and related symptom products. Specific current products, formulations, and market availability are not detailed in the supplied sources.

• 1985It tastes awful. And it works.

  Canada

  Buckley's mid-1980s advertising made the syrup's notoriously unpleasant taste the centerpiece of the brand proposition. Frank Buckley served as spokesperson, and the self-deprecating message framed the taste as a sign of the medicine's seriousness and effectiveness.

  Outcome. The campaign helped establish one of Canada's most recognizable over-the-counter medicine identities, although the supplied sources do not provide quantified campaign results.

  Source

• 2017Respond to packaging-related safety recallOther

  Health Canada identified a choking hazard associated with a faulty plastic seal on affected Buckley's products.

  What changed. Affected products were recalled in March 2017 under Health Canada's regulatory process.

  Aftermath. The incident placed product packaging and consumer safety at the center of attention for the affected products. The supplied sources do not specify the number of units, financial impact, or final corrective measures.

  Source
• 2016Discontinue Buckley's DM in CanadaOther

  Buckley's DM was a Canadian cough product containing dextromethorphan.

  What changed. The company stopped selling Buckley's DM in Canada while retaining other mixtures containing dextromethorphan, including Buckley's Dry Cough.

  Aftermath. Buckley's DM became a discontinued Canadian product; the supplied material does not state the commercial or regulatory reason for the decision.

  Source
• 2002Sell the company to NovartisM&A

  W. K. Buckley Limited had operated as a Canadian family-founded medicine company since 1919 and was known for its cough and cold products.

  What changed. Novartis acquired the company and incorporated the Buckley's brand into its multinational consumer-health operations.

  Aftermath. Buckley's continued as a Canadian consumer-health brand under Novartis ownership.

  Source

• 2017Health Canada recalls Buckley's products over faulty plastic seals

  Health Canada issued a recall in March 2017 after identifying a choking hazard connected with a faulty plastic seal on affected Buckley's products.

  RecallRegulation
  Source
• 2016Buckley's DM discontinued in Canada

  The company stopped selling Buckley's DM, a Canadian product containing dextromethorphan. Other Buckley's formulations containing the ingredient, including Buckley's Dry Cough, continued to be sold according to the supplied reference material.

  Product generationOther
  Source
• 2002W. K. Buckley Limited acquired by Novartis

  Novartis purchased W. K. Buckley Limited, bringing the Canadian cold-medicine business and its Buckley's brand into the multinational company's consumer-health operations.

  M&A
  Source

1. Buckley's
2. Buckley's official website